EUVIMEDEUVIMED entdecken
Crossref

Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab

Akifumi Kuwano, Kosuke Tanaka, Taikan Hamamoto, Kazuki Kurosaka, Hideo Suzuki, Masayoshi Yada, Yoshihiro Ohishi, Tomonari Sasaki, Kenta Motomura

Anticancer Research · 2025

DOI: 10.21873/anticanres.17903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Akifumi Kuwano und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan; akuwnaoh1@aih-net.com. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAntibodies, Monoclonal, HumanizedAntibodies, MonoclonalAntineoplastic Combined Chemotherapy ProtocolsHumansMaleFemaleMiddle AgedAgedProgression-Free SurvivalRetrospective StudiesAdultTreatment Outcome

Stichwörter der Autor:innen

Hepatocellular carcinomaabscopal effectobjective responseradiation therapytremelimumab–durvalumab

Substanzen

Antibodies, Monoclonal, HumanizedtremelimumabdurvalumabAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan; akuwnaoh1@aih-net.com.
  • Department of Hepatology, Aso Iizuka Hospital, Iizuka, Japan.
  • Department of Gastroenterology, Ichinomiyanishi Hospital, Ichinomiya, Japan.
  • Department of Diagnostic Pathology, Aso Iizuka Hospital, Iizuka, Japan.
  • Department of Radiation Oncology, Aso Iizuka Hospital, Iizuka, Japan.

Zitieren

APA

Kuwano, A., Tanaka, K., Hamamoto, T., Kurosaka, K., Suzuki, H., Yada, M., Ohishi, Y., Sasaki, T., & Motomura, K. (2025). Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab. Anticancer Research. https://doi.org/10.21873/anticanres.17903

Vancouver

Kuwano A, Tanaka K, Hamamoto T, Kurosaka K, Suzuki H, Yada M, et al. Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab. Anticancer Research. 2025. doi:10.21873/anticanres.17903

BibTeX
@article{Kuwano2025,
  author = {Kuwano, Akifumi and Tanaka, Kosuke and Hamamoto, Taikan and Kurosaka, Kazuki and Suzuki, Hideo and Yada, Masayoshi and Ohishi, Yoshihiro and Sasaki, Tomonari and Motomura, Kenta},
  title = {Prior Radiotherapy Improves Progression-free Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Tremelimumab–Durvalumab},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17903}
}
Kostenlos starten →